Literature DB >> 26863424

Circulating Retinoic Acid Levels and the Development of Metabolic Syndrome.

Yan Liu1, Hongen Chen1, Di Mu1, Jiahua Fan1, Jiayi Song1, Yuan Zhong1, Di Li1, Min Xia1.   

Abstract

CONTEXT AND
OBJECTIVE: In this prospective study, we evaluated the association of retinoic acid (RA) with the metabolic syndrome (MetS) in the Chinese population. DESIGN AND PARTICIPANTS: A total of 1042 nondiabetic adults from the population-based Nutrition and Health of Aging Population were prospectively followed up for 4 years. Serum RA concentrations was determined and its relationship with the MetS and its component was investigated.
RESULTS: At baseline, higher RA levels were inversely associated with the presence of MetS (odds ratio 0.61; 95% confidence interval [CI] 0.44–0.74, P < .001) after adjustment for age, gender, body mass index, the homeostasis model assessment index for insulin resistance (HOMA-IR), and other confounding factors. Subjects with lower RA levels had a progressively worse cardiometabolic risk profile at baseline. Serum RA levels were inversely associated with 8-iso-prostaglandin F2α (P < .001), high-sensitivity C-reactive protein (P = .015), and IL-6 (P = .020) and positively correlated with high-density lipoprotein cholesterol (P = .038). Among 825 subjects without MetS at baseline, 146 had developed it at 4 years. Serum RA by quartiles was inversely correlated with the incident MetS (adjusted hazard ratio 0.67; 95% CI 0.48–0.81, P = .006). Apart from HOMA-IR (P < .001), the baseline RA level was the only independent predictor of the development of the MetS during the 4-year follow-up (odds ratio 0.53; 95% CI 0.40–0.69; P < .001) after adjustment for age, gender, body mass index, and HOMA-IR.
CONCLUSIONS: The serum RA level is inversely associated with the development of MetS independently of adiposity and insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26863424     DOI: 10.1210/jc.2015-4038

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Fattening chips: hypertrophy, feeding, and fasting of human white adipocytes in vitro.

Authors:  Benjamin D Pope; Curtis R Warren; Madeleine O Dahl; Christina V Pizza; Douglas E Henze; Nina R Sinatra; Grant M Gonzalez; Huibin Chang; Qihan Liu; Aaron L Glieberman; John P Ferrier; Chad A Cowan; Kevin Kit Parker
Journal:  Lab Chip       Date:  2020-11-10       Impact factor: 6.799

2.  Effects of Mixed Carotenoids on Adipokines and Abdominal Adiposity in Children: A Pilot Study.

Authors:  J Atilio Canas; Amanda Lochrie; Amy Galena McGowan; Jobayer Hossain; Christopher Schettino; P Babu Balagopal
Journal:  J Clin Endocrinol Metab       Date:  2017-06-01       Impact factor: 5.958

3.  β-Carotene Oxygenase 1 Activity Modulates Circulating Cholesterol Concentrations in Mice and Humans.

Authors:  Jaume Amengual; Johana Coronel; Courtney Marques; Celia Aradillas-García; Juan Manuel Vargas Morales; Flavia C D Andrade; John W Erdman; Margarita Teran-Garcia
Journal:  J Nutr       Date:  2020-08-01       Impact factor: 4.798

Review 4.  Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disorders.

Authors:  William S Blaner
Journal:  Pharmacol Ther       Date:  2019-01-29       Impact factor: 12.310

Review 5.  Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).

Authors:  Ali Saeed; Robin P F Dullaart; Tim C M A Schreuder; Hans Blokzijl; Klaas Nico Faber
Journal:  Nutrients       Date:  2017-12-29       Impact factor: 5.717

6.  Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels.

Authors:  Ali Saeed; Joanne A Hoogerland; Hanna Wessel; Janette Heegsma; Terry G J Derks; Eveline van der Veer; Gilles Mithieux; Fabienne Rajas; Maaike H Oosterveer; Klaas Nico Faber
Journal:  Hum Mol Genet       Date:  2020-01-15       Impact factor: 6.150

7.  Quantification of All-Trans Retinoic Acid by Liquid Chromatography-Tandem Mass Spectrometry and Association with Lipid Profile in Patients with Type 2 Diabetes.

Authors:  Jakob Morgenstern; Thomas Fleming; Elisabeth Kliemank; Maik Brune; Peter Nawroth; Andreas Fischer
Journal:  Metabolites       Date:  2021-01-19

8.  Impaired CPT1A Gene Expression Response to Retinoic Acid Treatment in Human PBMC as Predictor of Metabolic Risk.

Authors:  Margalida Cifre; Andreu Palou; Paula Oliver
Journal:  Nutrients       Date:  2020-07-29       Impact factor: 5.717

9.  The Protection Conferred by HSD17B13 rs72613567 Polymorphism on Risk of Steatohepatitis and Fibrosis May Be Limited to Selected Subgroups of Patients With NAFLD.

Authors:  Eduardo Vilar-Gomez; Carlos J Pirola; Silvia Sookoian; Laura A Wilson; Tiebing Liang; Naga Chalasani
Journal:  Clin Transl Gastroenterol       Date:  2021-09-10       Impact factor: 4.488

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.